Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Capital Reinvestment Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd capital reinvestment ratio. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Capital Reinvestment Ratio of 7.78x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥24.04 Million) in capital expenditures (CN¥187.14 Million). Check 301126 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Capital reinvestment ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. This chart tracks Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore 301126 net asset momentum to track the company's year-over-year net asset growth rate.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Capital Reinvestment Ratio by Year (2019–2024)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see 301126 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.78x | CN¥24.04 Million | CN¥187.14 Million | ▼ -6.8% |
| 2023 | 8.36x | CN¥27.13 Million | CN¥226.70 Million | ▲ +3394.0% |
| 2019 | 0.24x | CN¥135.91 Million | CN¥32.50 Million | — |